SEC Form 4 · accession 0000886163-15-000115

LIGAND PHARMACEUTICALS INC · LGND

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Melanie J Herman

Officer — Director of Accounting

Period of report

Nov 11, 2015

Accepted (ET)

Nov 13, 2015 · 5:28 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000886163

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Nov 11, 2015	M	469	$11.15	A	3,620	D
Common Stock	Nov 11, 2015	M	625	$11.91	A	4,245	D
Common Stock	Nov 11, 2015	M	1,500	$14.47	A	5,745	D
Common Stock	Nov 11, 2015	M	312	$21.92	A	6,057	D
Common Stock	Nov 11, 2015	M	2,500	$74.42	A	8,557	D
Common Stock	Nov 11, 2015	M	625	$68.48	A	9,182	D
Common Stock	Nov 11, 2015	M	1,688	$56.26	A	10,870	D
Common Stock	Nov 11, 2015	S	7,719	$101.00	D	3,151	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1	$11.15	Nov 11, 2015	M	469	D	—	May 2, 2021	Common Stock	469	0	D
Employee Stock Option (right to buy)^F2	$11.91	Nov 11, 2015	M	625	D	—	Jan 3, 2022	Common Stock	625	250	D
Employee Stock Option (right to buy)^F3	$14.47	Nov 11, 2015	M	1,500	D	—	Feb 9, 2022	Common Stock	1,500	250	D
Employee Stock Option (right to buy)^F4	$21.92	Nov 11, 2015	M	312	D	—	Feb 15, 2023	Common Stock	312	1,000	D
Employee Stock Option (right to buy)^F5	$56.26	Nov 11, 2015	M	1,688	D	—	Feb 10, 2025	Common Stock	1,688	7,312	D
Employee Stock Option (right to buy)^F6	$68.48	Nov 11, 2015	M	625	D	—	Apr 1, 2024	Common Stock	625	3,625	D
Employee Stock Option (right to buy)^F7	$74.42	Nov 11, 2015	M	2,500	D	—	Feb 12, 2024	Common Stock	2,500	3,500	D

Explanation of responses

F1Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 05/02/2011.
F2Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 01/03/12.
F3Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/09/12.
F4Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/15/13.
F5Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/10/15.
F6Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 04/01/2014.
F7Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/12/14.